Previous issue | Volume 84 | ESPE2015 | Next issue

54th Annual ESPE

Barcelona, Spain
01 Oct 2015 - 03 Oct 2015

Card image cap
Barcelona, Spain; 1-3 October 2015 Further information

Poster Category 2

Hypo

Transient Hyperinsulinaemic Hypoglycaemia in Association with a Novel ABCC8 Mutation: Expanding the Clinical Phenotypes
aUCL Institute of Child Health, London, UK; bQueen Mary University London, London, UK; cCentral Manchester University Hospitals NHS Foundation Trust, Manchester, UK; dUniversity of Exeter Medical School, Exeter, UK
hrp0084p2-486
Congenital Hyperinsulinism in Ukraine
aUkrainian Scientific Centre of Endocrine Surgery, Kiev, Ukraine; bUniversity of Exeter Medical School, Exeter, UK; cHans Christian Andersen Children’s Hospital, Odense University Hospital, Odense, Denmark
hrp0084p2-487
Unexplained Altered States of Consciousness in a Girl
aDepartment of Paediatric Endocrinology, University Children’s Hospital Zurich, Zurich, Switzerland; bDepartment of Paediatric Oncology and Haematology, University Children’s Hospital Zurich, Zurich, Switzerland
hrp0084p2-488
The Effectiveness of Sirolimus in a Newborn with Hyperinsulinaemic Hypoglycaemia
aDiyarbakir Child Health Hospital, Pediatric Endocrinology, Diyarbakir, Turkey; bDiyarbakir Child Health Hospital, Neonatology, Diyarbakir, Turkey; cInstitute of Biomedical and Clinical Science, University of Exeter Medical School, Exeter, UK
hrp0084p2-489
Congenital Hyperinsulinism Caused by a Combination of Novel Heterozygous ABCC8 and KCNJ11 Mutations
aFaculty of Medicine, Department of Paediatrics, Charles University in Prague and University Hospital Motol, Prague, Czech Republic; bGenetics and Epigenetics in Health and Disease, Genetics and Genomic Medicine Programme, Institute of Child Health, University College London, London, UK; cDepartment of Paediatric Endocrinology, Great Ormond Street Hospital for Children NHS Trust, London, UK
hrp0084p2-490
Functional Analysis of Novel ABCC8 Mutations Found in Czech Patients with Congenital Hyperinsulinism
aFaculty of Medicine, Department of Paediatrics, Charles University in Prague and University Hospital Motol, Prague, Czech Republic; bGenetics and Epigenetics in Health and Disease, Genetics and Genomic Medicine Programme, Institute of Child Health, University College London, London, UK; cDepartment of Paediatric Endocrinology, Great Ormond Street Hospital for Children NHS Trust, London, UK; dFaculty of Medicine, Department of Paediatrics, Charles University in Prague and the General University Hospital in Prague, Prague, Czech Republic
hrp0084p2-491
Syndromic Hypoketotic, Hypoinsulinemic Hypoglycaemia due to a Mosaic Activating Phosphatidylinositol 3-Kinase Mutation
aDepartment of General Pediatrics, Neonatology and Pediatric Cardiology, University Hospital, Duesseldorf, Germany; bUniversity of Cambridge Metabolic Research Laboratories, Cambridge, UK; cThe Wellcome Trust Sanger Institute, Cambridge, UK
hrp0084p2-492
Long Acting Somatostatin Analogue (Lanreotide) Therapy in Congenital Hyperinsulinism - Pharmacokinetics and Long-Term Follow-Up Study
aUniversity College London Institute of Child Health, London, UK; bGreat Ormond Street Hospital for Children NHS Foundation Trust, London, UK; cAlder Hey Children’s Hospital NHS Trust, Liverpool, UK; dKymos Pharma Services, Barcelona, Spain
hrp0084p2-493
Congenital Hyperinsulinism in Association with Poland Syndrome and Chromosome 10p11-p13 Duplication
aAlder Hey Children’s Hospital, Liverpool, UK; bLiverpool Women’s Hospital, Liverpool, UK; cWrexham Maelor Hospital, Wrexham, UK
hrp0084p2-494